Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Yasuhiro KatsumataDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Correspondence[email protected]
View further author information

Yuko OkamotoDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information

Takahito MoriyamaDepartment of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan Kidney Center, TokyoView further author information

Rina MoriyamaDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information

Manabu KawamotoDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information

Masanori HanaokaDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information

Keiko UchidaDepartment of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan Kidney Center, TokyoView further author information

Kosaku NittaDepartment of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan Kidney Center, TokyoView further author information

Masayoshi HarigaiDepartment of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; View further author information

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Omar Ragy, Vilma Rautemaa, Alison Smith, Paul Brenchley, Durga Kanigicherla & Patrick Hamilton. (2023) Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?. PLOS ONE 18:2, pages e0281726.
Crossref

Syoko Tsubouchi, Takahiro Mizuuchi, Yusuke Yamamoto, Daiki Fujimori, Kayo Ishii, Mayu Tago, Eri Kato, Hiroaki Mori, Haeru Hayashi, Koichiro Tahara & Tetsuji Sawada. (2022) Nephrotic Syndrome as an Extramuscular Manifestation of Anti-EJ Antibody-Positive Dermatomyositis: A Case Report and Review of the Literature. Case Reports in Rheumatology 2022, pages 1-9.
Crossref

Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir & Joško Božić. (2022) Emerging Biomarkers for Early Detection of Chronic Kidney Disease. Journal of Personalized Medicine 12:4, pages 548.
Crossref

Le Deng, Qipeng Huang, Jiang Wang, Kaiping Luo, Jiarong Liu, Wenjun Yan, Fang Jiang & Gaosi Xu. (2022) Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer. Frontiers in Pharmacology 12.
Crossref

Chaofan Li, Ping Li, Wenkai Guo, Lei Chen, Jiatong Li, Rong Wang & Bing Chen. (2022) The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study. The Korean Journal of Internal Medicine 37:1, pages 154-166.
Crossref

Nicholas Meyer, Wendy Cooper, Paul Kirwan, Roger Garsia, Scott Dunkley & David M. Gracey. (2021) Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab – case report and review of the literature. BMC Nephrology 22:1.
Crossref

Brunetta Porcelli, Andrea Guarnieri, Fabio Ferretti, Guido Garosi, Lucia Terzuoli, Francesca Cinci, Antonella Tabucchi, Marilina Tampoia, Letizia Abbracciavento, Chiara Villani, Gaia Deleonardi, Ana Gabriela Grondona, Marcello Mazzolini, Gaetano La Manna, Marisa Santostefano, Maria Infantino, Mariangela Manfredi, Giuseppe Spatoliatore, Alberto Rosati, Chiara Somma & Nicola Bizzaro. (2020) Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience. Journal of Nephrology 34:2, pages 573-579.
Crossref

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date